Head and Neck Cancer and the Elderly Patient

Brian P. Cervenka, Shyam Rao, Arnaud Bewley

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Management of head and neck cancer in the elderly patient is particularly challenging given the high morbidity associated with treatment. Surgery, radiotherapy, and chemotherapy have all been demonstrated as effective in older patients; however, older patients are more susceptible to treatment-induced toxicity, which can limit the survival benefits of certain interventions. This susceptibility is better associated with the presence of multiple comorbidities and decreasing functional status than with age alone. Screening tools allow for risk stratification, treatment deintensification, and even treatment avoidance in patients who are deemed at high-risk of being harmed by standard therapy.

Original languageEnglish (US)
JournalOtolaryngologic Clinics of North America
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Head and Neck Neoplasms
Therapeutics
Comorbidity
Radiotherapy
Morbidity
Drug Therapy
Survival

Keywords

  • Chemotherapy
  • Comprehensive elderly assessment
  • Elderly medicine
  • Head and neck cancer
  • Radiation therapy
  • Surgical therapy

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Head and Neck Cancer and the Elderly Patient. / Cervenka, Brian P.; Rao, Shyam; Bewley, Arnaud.

In: Otolaryngologic Clinics of North America, 01.01.2018.

Research output: Contribution to journalArticle

@article{00de3f4987704f6ea774b9f95bd3f091,
title = "Head and Neck Cancer and the Elderly Patient",
abstract = "Management of head and neck cancer in the elderly patient is particularly challenging given the high morbidity associated with treatment. Surgery, radiotherapy, and chemotherapy have all been demonstrated as effective in older patients; however, older patients are more susceptible to treatment-induced toxicity, which can limit the survival benefits of certain interventions. This susceptibility is better associated with the presence of multiple comorbidities and decreasing functional status than with age alone. Screening tools allow for risk stratification, treatment deintensification, and even treatment avoidance in patients who are deemed at high-risk of being harmed by standard therapy.",
keywords = "Chemotherapy, Comprehensive elderly assessment, Elderly medicine, Head and neck cancer, Radiation therapy, Surgical therapy",
author = "Cervenka, {Brian P.} and Shyam Rao and Arnaud Bewley",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.otc.2018.03.004",
language = "English (US)",
journal = "Otolaryngologic Clinics of North America",
issn = "0030-6665",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Head and Neck Cancer and the Elderly Patient

AU - Cervenka, Brian P.

AU - Rao, Shyam

AU - Bewley, Arnaud

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Management of head and neck cancer in the elderly patient is particularly challenging given the high morbidity associated with treatment. Surgery, radiotherapy, and chemotherapy have all been demonstrated as effective in older patients; however, older patients are more susceptible to treatment-induced toxicity, which can limit the survival benefits of certain interventions. This susceptibility is better associated with the presence of multiple comorbidities and decreasing functional status than with age alone. Screening tools allow for risk stratification, treatment deintensification, and even treatment avoidance in patients who are deemed at high-risk of being harmed by standard therapy.

AB - Management of head and neck cancer in the elderly patient is particularly challenging given the high morbidity associated with treatment. Surgery, radiotherapy, and chemotherapy have all been demonstrated as effective in older patients; however, older patients are more susceptible to treatment-induced toxicity, which can limit the survival benefits of certain interventions. This susceptibility is better associated with the presence of multiple comorbidities and decreasing functional status than with age alone. Screening tools allow for risk stratification, treatment deintensification, and even treatment avoidance in patients who are deemed at high-risk of being harmed by standard therapy.

KW - Chemotherapy

KW - Comprehensive elderly assessment

KW - Elderly medicine

KW - Head and neck cancer

KW - Radiation therapy

KW - Surgical therapy

UR - http://www.scopus.com/inward/record.url?scp=85047293933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047293933&partnerID=8YFLogxK

U2 - 10.1016/j.otc.2018.03.004

DO - 10.1016/j.otc.2018.03.004

M3 - Article

C2 - 29801920

AN - SCOPUS:85047293933

JO - Otolaryngologic Clinics of North America

JF - Otolaryngologic Clinics of North America

SN - 0030-6665

ER -